Sign in
4

Changes in Ownership

Bolt Biotherapeutics, Inc. Filed Acc 0000899243-22-007524

Options or other derivatives

  • Chief Financial Officer acquired 210,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Quinn William P. Chief Financial Officer 2022-02-18 Grant or award · Stock Option (Right to Buy) +210,000 210,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…